Renal safety of initial combination versus single DMARD therapy in patients with early rheumatoid arthritis: An 11-year experience from the FIN-RACo trial

Clinical and Experimental Rheumatology

Volumn 28, Issue 1, 2010, Pages 73-78

  Karstila, Krista L ^a   Rantalaiho, V M ^a   Mustonen, J T ^a,b   Mottonen T T ^c   Hannonen, P J ^d   Leirisalo Repo, M ^e   Kaipiainen Seppanen O A ^f   Karjalainen, A H ^g   Korpela, M M ^a  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

^b TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^c TURKU UNIVERSITY HOSPITAL   (Finland)

^d JYVÄSKYLÄ CENTRAL HOSPITAL   (Finland)

^e HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^f KUOPIO UNIVERSITY HOSPITAL   (Finland)

^g OULU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Chronic kidney failure; Combination drug therapy; DMARD; Haematuria; Proteinuria; Rheumatoid arthritis

Indexed keywords

CREATININE; CYCLOSPORIN; DISEASE MODIFYING ANTIRHEUMATIC DRUG; HYDROXYCHLOROQUINE; METHOTREXATE; PREDNISOLONE; SALAZOSULFAPYRIDINE;

ADULT; AGED; ARTICLE; COMBINATION CHEMOTHERAPY; COMPARATIVE STUDY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; FEMALE; GLOMERULUS FILTRATION RATE; HEMATURIA; HUMAN; KIDNEY BIOPSY; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICATION THERAPY MANAGEMENT; MONOTHERAPY; NEPHROTOXICITY; PRIORITY JOURNAL; PROTEINURIA; REMISSION; RENAL PROTECTION; RHEUMATOID ARTHRITIS; SIDE EFFECT; URINALYSIS;

ADULT; AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HEMATURIA; HUMANS; HYDROXYCHLOROQUINE; INCIDENCE; KIDNEY DISEASES; MALE; METHOTREXATE; MIDDLE AGED; PREDNISOLONE; PREVALENCE; PROTEINURIA; SULFASALAZINE; YOUNG ADULT;

EID: 77949507143     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. AMERICAN COLLEGE OF RHEUMATOLOGY AD HOC COMMITTEE ON CLINICAL GUIDELINES: Guidelines for the management of rheumatoid arthritis. Arthritis Rheum 1996; 39: 713-22.
2. MÖTTÖNEN T, HANNONEN P, LEIRISALOREPO M et al.: Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial. Lancet 1999; 353: 1568-73.
3. LANDEWE RB, BOERS M, VERHOEVEN A et al.: COBRA combination therapy in patients with early rheumatoid arthritis. Arthritis Rheum 2002; 46: 347-56.
4. KORPELA M, LAASONEN L, HANNONEN P et al.: Retardation of joint damage in patients with early rheumatoid arthritis by initial aggressive treatment with disease-modifying antirheumatic drugs. Arthritis Rheum 2004; 50: 2072-81.
5. GRIGOR C, CAPELL H, STIRLING A et al.: Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial. Lancet 2004; 364: 263-9.
6. UUTELA T, HANNONEN P, KAUTIAINEN H, HAKALA M, PAANANEN M-L, HÄKKINEN A: Positive treatment response improves the health-related quality of life of patients with early rheumatoid arthritis. Clin Exp Rheumatol 2009; 27: 108-11.
7. SORENSEN AWS: The kidney function in patients with rheumatoid arthritis in relation to commencement of the disease. Acta Rheum Scand 1964; 10: 11-28.
8. RICHARDS IM, FRASER SM, CAPELL HA, FOX JG, BOULTON-JONES JM: A survey of renal function in outpatients with rheumatoid arthritis. Clin Rheumatol 1988; 7: 267-71.
9. BOERS M, DIJKMANS BAC, BREEDVELD FC et al.: Subclinical renal dysfunction in rheumatoid arthritis. Arthritis Rheum 1990; 33: 95-101.
10. KORPELA M, MUSTONEN J, HEIKKINEN A, HELIN H, PASTERNACK A: Isolated microscopic hematuria in patients with rheumatoid arthritis compared with age and sex matched controls. A population based study. J Rheumatol 1995; 22: 427-31.
11. KORPELA M: Rheumatoid arthritis and the kidneys - A cross-sectional study on prevalence, clinical significance and risk of renal and urinary tract diseases in patients with rheumatoid arthritis. Helsinki, Publications of the Social Insurance Institution, 1993, ML:122.
12. KOSEKI Y, TERAI C, MORIGUCHI M, UESATO M, KAMATANI N: A prospective study of renal disease in patients with early rheumatoid arthritis. Ann Rheum Dis 2001; 60: 327-31.
13. RANTALAIHO V, KORPELA M, HANNONEN P et al.: The good initial response to therapy with a combination of traditional diseasemodifying antirheumatic drugs is sustained over time. The eleven-year results of the Finnish rheumatoid arthritis combination therapy trial. Arthritis Rheum 2009; 60: 1222-31.
14. ARNETT FC, EDWORTHY SM, BLOCH DA et al.: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24.
15. COCKCROFT DW, GAULT MH: Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31-41.
16. LEONARD PA, BIENZ SR, CLEGG DO, WARD JR: Hematuria in patients with rheumatoid arthritis receiving gold or D-penicillamine. J Rheumatol 1987; 14: 55-9.
17. KORPELA M, MUSTONEN J, HEIKKINEN A, HELIN H, PASTERNACK A: Isolated microscopic hematuria in patients with rheumatoid arthritis compared with age and sex matched controls. A population based study. J Rheumatol 1995; 22: 427-31.
18. HELIN H, KORPELA M, MUSTONEN J, PASTERNACK A: Mild mesangial glomerulopathy-a frequent finding in rheumatoid arthritis patients with hematuria or proteinuria. Nephron 1986; 42: 224-30.
19. HORDON LD, SELLARS L, MORLEY AR, WILKINSON R, THOMPSON M, GRIFFITHS ID: Hematuria in rheumatoid arthritis: an association with mesangial glomerulonephritis. Ann Rheum Dis 1984; 43: 440-3.
20. POLLET S, DEPNER T, MOORE P, OLANDER H, ROBBINS D: Mesangial glomerulopathy and IgM Rheumatoid factor in rheumatoid arthritis. Nephron 1989; 51: 107-11.
21. CANTAGREL A, POURRAT J, FOURNIE B, CONTE JJ, FOURNIE A: Renal involvement in the course of rheumatoid polyarthritis. Rev Rheum Mal Osteoartric 1990; 57: 303-7.
22. KORPELA M, MUSTONEN J, TEPPO A-M, HELIN H, PASTERNACK A: Mesangial glomerulonephritis as an extra-articular manifestation of rheumatoid arthritis. Br J Rheumatol 1997; 36: 1189-95.
23. SIHVONEN S, KORPELA M, MUSTONEN J, LAIPPALA P, PASTERNACK A: Renal disease as a predictor of increased mortality among patients with rheumatoid arthritis. Nephron Clin Pract 2004; 96: c107-c114.
24. KARSTILA K, KORPELA M, SIHVONEN S, MUSTONEN J: Prognosis of clinical renal disease and incidence of new renal findings in patients with rheumatoid arthritis: follow-up of a population based study. Clin Rheumatol 2007; 26: 2089-95.
25. NIVED O, STURFELT G, WESTLING H, WHITE T: Is serum creatinine concentration a reliable index of renal function in rheumatic diseases? Br Med J 1983; 286: 684-5.
26. LAIHO K, KAARELA K, KAUTIAINEN H, KAUPPI M: Evaluation of renal function in patients with rheumatoid arthritis and amyloidosis. Clin Rheumatol 2001; 20: 453-4.
27. 51Cr-EDTA clearance. Nephron Clin Pract. 2008; 108: c284-c290.
28. PERRONE RD, MADIAS NE, LEVEY AS: Serum creatinine as an index of renal function: New insights into old concepts. Clin Chem 1992; 38: 1933-53.